Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers

Benzer Materyaller

• Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers
  Yazar:: Gu N, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-10-01)
• Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
  Yazar:: Rhee, Su-jin, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
  Yazar:: Lim, Kyoung Soo, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects
  Yazar:: Yoo, Hyounggyoon, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
  Yazar:: Hwang, Inyoung, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)